Georgia's Online Cancer Information Center

Our Purpose

Cancer is Georgia’s second-leading cause of death, yet many of its devastating effects are preventable or controllable – sometimes curable, and always more effectively treated when detected early. Clinical trials offer great promise for controlling cancer and its progression while navigation and survivorship services enhance quality of care for patients and quality of life for survivors.

This is why Georgia CORE was created. 

A public-private partnership that connects providers, researchers, leaders, organizations, and advocates, Georgia CORE is led by a Board of Directors of experts from cancer centers, hospitals and educational and academic institutions. We build and nurture collaboration that increases access to innovative resources and research and personalized cancer care and support for patients, survivors, and caregivers. We are a unique statewide organization working with  a vast array of groups – from local hospitals and community organizations to public health centers and the National Cancer Institute – leveraging public and private funding to provide greater impact and generate improved results.

Take a look at our latest Impact Report >

See where we are headed in our current strategic plan >>

Read more about how Georgia CORE came to be >

Won't you support our effort?

Last Updated: 2/11/2025 1:39:29 PM

About Us

Georgia CORE releases FY24 Impact Report

Get the latest from the center of Georgia's cancer fight from our FY24 Impact Report and also a message from the President.

12/18/2024

 About

‘It’s working!’ Columbus cancer center is first in Georgia to administer this new therapy

Health care providers at the John B. Amos Cancer Center in Columbus, Georgia are the first in the state to administer a new therapy for cancer treatment, called BiTE therapy.

2/14/2025

Georgia CORE introduces a resource guide for barriers to cancer clinical trials

We invite you to download and share it, and let us know if there is anything we should add to it.

1/14/2025